Condition
Cholera Vaccination Reaction
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 2 (1)
Trial Status
Not Yet Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07270796Phase 1Not Yet RecruitingPrimary
Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants
NCT07107516Phase 1Not Yet RecruitingPrimary
Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers
NCT05559983Phase 1CompletedPrimary
Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
NCT03719066Phase 2Completed
Extended Dose Intervals With Oral Cholera Vaccine in Cameroon
Showing all 4 trials